Home' Australian Pharmacist : Australian Pharmacist February 2014 Contents Australian Pharmacist February 2014 I ©Pharmaceutical Society of Australia Ltd.
2014 PBS co-payment
The PBS co-payment and safety net
amounts were revised in line with
changes in the consumer price index
from 1 January. The general patient
co-payment increased from $36.10 to
$36.90; the concessional co-payment
increased from $5.90 to $6. The general
safety net threshold increased from
$1,390.60 to $1,421.20 and the
concessional safety net increased from
$354 to $360. For more information
e-Health record review
The review of the Personally Controlled
Electronic Health Records (PCEHR)
system was completed and delivered
to Health Minister Peter Dutton on
20 December. The review team headed
by the Executive Director of the
UnitingCare Health Group, Mr Richard
Royle looked into concerns about
the progress and implementation
of the PCEHR. A statement from the
Minister said that the report provides
a comprehensive plan for the future of
electronic health records in Australia.
Mr Dutton said the Government was
committed to getting the electronic
health record back on track and would
take time to consider the review
New date for conference
Pharmacy 2014 -- The Pharmacy
Management Conference has been
brought forward and will now be
held from Wednesday 30 July until
Friday 1 August at the Surfers Paradise
Marriott, on Queensland's Gold
Coast. Organisers said, 'to miss some
unavoidable timetable clashes, we
have brought the conference forward
so that our delegates and sponsors
can plan accordingly and not be
hamstrung by conflicting events. We've
also shortened our innovative and
thought-provoking program slightly,
running it over two and a half days.
Former secretary and registrar
of the Royal Pharmaceutical
Society of Great Britain (RPSGB),
Ann Lewis has died. She was aged
Federation Vice President and former
Association President John Bell paid
tribute to Miss Lewis.
He said: 'Ann Lewis' widely
acknowledged professional expertise
and wonderfully good humour will
be sorely missed, not only in the UK,
but also internationally.
'During her time on the RPSGB Council
(she served two terms as President)
and later during her nearly 10 years
as Secretary/Registrar, she provided
great personal and organisational
support for the Commonwealth
'In my own role as CPA President
I worked closely with Ann and greatly
valued her counsel and her friendship,'
Mr Bell said.
RPSGB President Martin Astbury said:
'Ann was a strong and effective leader
nationally while never forgetting her
North Wales and Chester roots.'
RPSGB chief executive Helen Gordon
added: 'Ann's dedication to the RPS and
to pharmacy was apparent to all who
worked with her and knew her. She will
be sorely missed'.
Miss Lewis registered as a pharmacist
in 1965. She also graduated with a law
degree in 1973 and was called to the
bar in 1980. She was appointed district
pharmaceutical officer for the Chester
and Halton Health Authorities in 1983
and served as director of pharmaceutical
services for the Countess of Chester
Hospital NHS Trust from 1993 to 1996.
Miss Lewis became joint director of
the Centre for Postgraduate Pharmacy
Education in 1996, following a two-
year term as President of the RPSGB.
She served as a member of the Society's
Council from 1987 to 1998, when she
became secretary and registrar.
In recognition of her achievements,
Miss Lewis was made an OBE in 1997.
She received the RPS Charter gold medal
Medicines Australia (MA) has
welcomed the introduction of an
extended 10-week publication time
for Pharmaceutical Benefits Advisory
Committee (PBAC) meeting agendas.
The agenda for each PBAC meeting will
now be published 10 weeks before the
meeting. Previously was published six
weeks before the meeting.
MA Chief Executive Dr Brendan Shaw
said that the longer time period
means consumers, consumer groups,
and members of the general public have
more time to prepare submissions and
make comments to the PBAC on new
medicines and vaccines seeking listing
on the Pharmaceutical Benefits Scheme.
'Industry has worked with government,
technical experts and patient
groups to secure this improvement
to the PBAC system. This included
having to manage important
'Industry supports this increase in
transparency because it makes sense,
it's practical, it's meaningful and it
serves a real purpose for the end user --
'It's an example of what can be achieved
when stakeholders work collaboratively
with industry on an important policy
issue. Some years ago, industry worked
with government and consumer groups
to have the PBAC agenda published
which was a real innovation at the time.
Now we have agreed to publish the
agenda earlier to give people more time
to input into the PBAC process'.
Links Archive Australian Pharmacist January 2014 Australian Pharmacist March 2014 Navigation Previous Page Next Page